Micro Emerging Active

PFE TALZENNA Phase 3 Résultats

New narrative with limited coverage — still forming.

Score
0,3
Vélocité
▲ 0,0
Articles
2
Sources
1

Sentiment Timeline

Event Timeline

Mar 28, 2026
Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data Bullish
Mar 27, 2026
Pfizer Inc. (PFE) Announces Positive Topline Results From Phase 3 TALAPRO-3 Study … Neutral

Chronologie

Première observationMar 27, 2026
Dernière mise à jourMar 27, 2026